Antimicrobial enzymes: An emerging strategy to fight microbes and microbial biofilms

Biotechnology Journal

Volumn 8, Issue 1, 2013, Pages 97-109

  Thallinger, Barbara ^a   Prasetyo, Endry N ^a   Nyanhongo, Gibson S ^a   Guebitz, Georg M ^a,b  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Anti biofilm enzymes; Antimicrobial enzymes; Microbial biofilm

Indexed keywords

ANTI-BIOFILM; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ENZYMES; BIOFILM FORMATION; BIOMEDICAL INDUSTRY; CELLULAR MACHINERY; ENZYME ENGINEERING; MICROBIAL BIOFILM; QUORUM-SENSING; SYNTHETIC BIOLOGY;

BIOFILMS; GENE ENCODING; HEALTH CARE; MACHINERY; MICROORGANISMS;

ENZYMES;

ALGINATE LYASE; AMYLASE; ANTIINFECTIVE AGENT; HYDROGEN PEROXIDE; LYSINE; LYSOSTAPHIN; MICROBIAL ENZYME; PENICILLIN DERIVATIVE; PROTEIN; SUBTILISIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOPHAGE; BIOFILM; COMPLEX FORMATION; DNA SEQUENCE; ENVIRONMENTAL PROTECTION; ENZYME ACTIVITY; ENZYME DEGRADATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOFILMS; ENZYMES; HUMANS;

BACTERIA (MICROORGANISMS);

EID: 84871802508     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201200313     Document Type: Article

References (145)

1. Flemming, H., Wingender, J., The biofilm matrix. Nat. Rev. Micro. 2010, 8, 623-633.
2. Leslie, A., Preventing biofilm formation using microbes and their enzymes. MMG 445 Basic Biotechnology 2011, 7:6-11.
3. Jass, J., Walker, J.T., Biofilms and biofouling, in: Walker, J.T., Surman, S., Jass, J. (Eds.), Industrial Biofouling: Detection, Prevention and Control, Wiley, New York, 2000, pp. 1-12.
4. Parsek, M.R., Singh, P.K., Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 2003, 57, 677-701.
5. Alekshun, M.N., Levy, S.B., Molecular mechanisms of antibacterial multidrug resistance. Cell 2007, 128, 1037-1050.
6. Klein, J.O., Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections. Am. J. Manag. Care 2002, 8, S345-S352.
7. Charles, P.G., Grayson, M.L., The dearth of new antibiotic development: why we should be worried and what we can do about it. Med. J. Aust. 2004, 181, 549-553.
8. Brötz-Oesterhelt, H., Sass, P., Postgenomic strategies in antibacterial drug discovery. Future Microb. 2010, 5, 1553-1579.
9. Hansen, E.H., Schembri, M.A., Klemm, P., Schäfer, T. et al., Elucidation of the antibacterial mechanism of the Curvularia Haloperoxidase system by DNA microarray profiling. App. Environ. Microbiol. 2004, 70, 1749-1757.
10. Wenk, C., Recent advances in animal feed additives such as metabolic modifiers, antimicrobial agents, probiotics, enzymes and highly available minerals. Asian-Aus. J. Anim. Sci. 2000, 13, 86-95.
11. Costerton, J.W., Stewart, P.S., Greenberg, E.P., Bacterial biofilms: a common cause of persistent infections. Science 1999, 284, 1318-1322.
12. Stickler, D.J., Bacterial biofilms in patients with indwelling urinary catheters. Nature Clin. Pract. 2008, 5, 598-60.
13. Lazar, V., Quorum sensing in biofilms Anaerobe. 2011, 17: 280-28.
14. Fernandes, P., Antibacterial discovery and development: the failure of success? Nat. Biotechnol. 2006, 24, 1497-1503.
15. Lange, R.P., Locher, H.H., Wyss, C.P., Then, R.L., The targets of currently used antibacterial agents: lessons for drug discovery. Curr. Pharm. Design 2007, 13, 3140-3154.
16. Davies, J., Davies, D., Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. R. 2010, 74, 417-433.
17. CDC, Staphylococcus aureus resistant to vancomycin. Morb. Mortal. Wkly. Rep. 2002, 51, 565-567.
18. Nikaido, H., Multidrug Resistance in Bacteria. Annu. Rev. Biochem. 2009, 78, 119-146.
19. Simões, M., Simões, L. C., Vieira, M. J., A review of current and emergent biofilm control strategies. LWT - Food Sci. Technol. 2010, 43, 573-583.
20. Sumantha, A., Larroche, C., Pandey, A., Microbiology and industrial biotechnology of food-grade proteases: a perspective. Food Technol. Biotechnol. 2006, 44, 211-220.
21. Augustin, M., Ali-Vehmas, T., Atroshi, F., Assessment of enzymatic cleaning agents and disinfectants against bacterial biofilms. J. Pharm. Pharm. Sci. 2004, 7, 55-64.
22. Hedstrom, L., Serine protease mechanism and specificity. Chem. Rev. 2002, 102, 4501-4524.
23. Longhi, C., Scoarughi, G. L., Poggiali, F., Cellini, A. et al., Protease treatment affects both invasion ability and biofilm formation in Listeria monocytogenes. Microb. Pathog. 2008, 45, 45-52.
24. Molobela, P., Cloete, T., Beukes, E.M., Protease and amylase enzymes for biofilm removal and degradation of extracellular polymeric substances (EPS) produced by Pseudomonas fluorescens bacteria. Afr. J. Microbiol. Res. 2010, 4, 1515-1524.
25. Leroy, C., Delbarre, C., Ghillebaert, F., Compere, C. et al., Effects of commercial enzymes on the adhesion of a marine biofilm-forming bacterium. Biofouling 2008, 24, 11-22.
26. Ledder, R. G., Madhwani, T., Sreenivasan, P. K., De Vizio, W. et al., An in vitro evaluation of hydrolytic enzymes as dental plaque control agents. J. Medic. Microbiol. 2009, 58, 482-491.
27. Marcato-Romain, C., Pechaud, Y., Paul, E., Girbal-Neuhauser, E. et al., Removal of microbial multi-species biofilms from the paper industry by enzymatic treatments. Biofouling 2012, 28, 305-314.
28. Catara, G., Ruggiero, G., Cara, F., Digilio, F. A. et al., A novel extracellular subtilisin-like protease from the hyperthermophile Aeropyrum pernix K1: biochemical properties, cloning, and expression. Extremophiles 2003, 7, 391-399.
29. Kokai-Kun, J. F., Walsh, S. M., Chanturiya, T., Mond, J.J., Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 2003, 47, 1589-1597.
30. Kumar, J., Lysostaphin: an antistaphylococcal agent. Appl. Microbiol. Biotechnol. 2008, 80, 555-561.
31. Kumar, A., Vemula, P.K., Ajayan, P.M., John, G., Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. Nat. Mater. 2008, 7, 236-241.
32. Recsei, P. A., Gruss, A. D., Novick, R. P., Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans. Proc. Nat. Acad. Sci. USA. 1987, 84, 1127-1131.
33. Mierau, I., Leij, P., Van Swam, I., Blommestein, B. et al., Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin. Microbial Cell Fact. 2005, 4, 15.
34. Miao, J., Pangule, R.C., Paskaleva, E.E., Hwang, E.E. et al., Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials 2011, 32, 9557-9567.
35. Belyansky, I., Tsirline, V.B., Martin, T.R., Klima, D.A. et al., The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength. J. Surg. Res. 2011, 171, 409-415.
36. Satishkumar, R., Sankar, S., Yurko, Y., Lincourt, A. et al., Evaluation of the Antimicrobial activity of lysostaphin-coated Hernia repair meshes. Antimicrob. Agents Chemother. 2011, 55, 4379-4385.
37. Shah, A., Mond, J., Walsh, S., Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization. Antimicrob. Agents Chemother. 2004, 48, 2704-2707.
38. Pangule, R.C., Brooks, S.J., Dinu, C.Z., Bale, S.S. et al., Antistaphylococcal nano composite films based on enzyme nanotube conjugates. ACS Nano 2010, 4, 3993-4000.
39. Placencia, F.X., Kong, L., Weisman, L.E., Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin. Pediatr. Res. 2009, 65, 420-424.
40. Kokai-Kun, J.F., Chanturiya, T., Mond, J.J., Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model. J. Antimicrob. Chemother. 2007, 60, 1051-1059.
41. Dixon, R.E., Goodman, J.S., Koenig, M.G., Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice. Yale J. Biol. Med. 1968, 41, 62-68.
42. Kiri, N., Archer, G., Climo, M.W., Combinations of lysostaphin with β-Lactams are synergistic against Oxacillin-resistant Staphylococcus epidermidis. Antimicrob. Agents Chemother. 2002, 46, 2017-2020.
43. Wall, R.J., Powell, A.M., Paape, M.J., Kerr, D.E. et al., Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat. Biotechnol. 2005, 23, 445-451.
44. Hermoso, J.A., García, J.L., García, P., Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr. Opin. Microbiol. 2007, 10, 461-472.
45. Kutter, E., Sulakvelidze, A., Introduction, in: Kutter, E., Sulakvelidze, A. (Eds.), Bacteriophages Biology and Applications, CRC Press, 2005, pp. 1-4.
46. Loessner, M.J., Bacteriophage endolysins - current state of research and applications. Curr. Opin. Microbiol. 2005, 8, 480-487.
47. Navarre, W.W., Ton-That, H., Faull, K.F., Schneewind, O., Multiple enzymatic activities of the murein hydrolase from staphylococcal Phage f11. J. Biol. Chem. 1999, 274, 15847-15856.
48. Borysowski, J., Weber-Dabrowska, B., Górski, A., Bacteriophage endolysins as a novel Class of antibacterial Agents. J. Exp. Biol. Med 2006, 231, 366-377.
49. Loeffler, J.M., Djurkovic, S., Fischetti, V.A., Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect. Immun. 2003, 71, 6199-6204.
50. Fenton, M., Ross, P., McAuliffe, O., O'Mahony, J. et al., Recombinant bacteriophage lysins as antibacterials. Bioeng. Bugs 2010, 1, 9-16.
51. Jado, I., López, R., García, E., Fenoll, A. et al., Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J. Antimicrob. Chemother. 2003, 52, 967-973.
52. Schuch, R., Nelson, D., Fischetti, V.A., A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 2002, 418, 884-889.
53. Yoong, P., Schuch, R., Nelson, D., Fischetti, V.A., Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J. Bacteriol. 2004, 186, 4808-4812.
54. Hibma, A.M., Jassim, S.A.A., Griffiths, M.W., Infection and removal of L-forms of Listeria monocytogenes with bred bacteriophage. Int. J. Food Microbiol. 1997, 34, 197-207.
55. Sharma, M., Ryu, J., Beuchat, L.R., Inactivation of Escherichia coli O157:H7 in biofilm on stainless steel by treatment with an alkaline cleaner and a bacteriophage. J. Appl. Microbiol. 2005, 99, 449-459.
56. Gaeng, S., Scherer, S., Neve, H., Loessner, M.J., Gene cloning and expression and secretion of Listeria monocytogenes bacteriophage-lytic enzymes in Lactococcus lactis. App. Environ. Microbiol. 2000, 66, 2951-2958.
57. Düring, K., Porsch, P., Fladung, M., Lörz, H., Transgenic potato plants resistant to the phytopathogenic bacterium Erwinia carotovora. Plant J. 1993, 3, 587-598.
58. Mandel, I.D., The New Toothpastes. J. Calif. Dental Assoc. 1998.
59. Rodeheaver, G., Marsh, D., Edgerton, M.T., Edlich, R.F., Proteolytic enzymes as adjuncts to antimicrobial prophylaxis of contaminated wounds. Am. J. Surg. 1975, 129, 537-544.
60. Laschtschenko, P., Uber die keimtötende und entwicklungshemmende Wirkung von Hühnereiweiβ. Med. Microbiol. Immunol. 1909, 64, 419-427.
61. Glynn, A., Lysozyme: antigen, enzyme and antibacterial agent. Sci. Basis Med. Annu. Rev. 1968, 31.
62. Arnheim, N., Wilson, A. C., Quantitative immunological comparison of bird lysozymes. J. Biol. Chem. 1967, 242, 3951-3956.
63. Proctor, V.A., Cunningham, F. E., Fung, D.Y.C., The chemistry of lysozyme and its use as a food preservative and a pharmaceutical. Crit. Rev. Food Sci. Nutr. 1988, 26, 359-395.
64. Cunningham, F.E., Proctor, V.A., Goetsch, S.J., Egg-white lysozyme as a food preservative: an overview. World's Poult. Sci. J. 1991, 47, 141.
65. Buonocore, G.G., Conte, A., Corbo, M.R., Sinigaglia, M. et al., Mono- and multilayer active films containing lysozyme as antimicrobial agent. Innov. Food Sci. Emerg. 2005, 6, 459-464.
66. Edwards, J., Prevost, N., Condon, B., French, A. et al., Immobilization of lysozyme-cellulose amide-linked conjugates on cellulose I and II cotton nano crystalline preparations. Cellulose 2012, 19, 495-506.
67. Lian, Z., Ma, Z., Wei, J., Liu, H., Preparation and characterization of immobilized lysozyme and evaluation of its application in edible coatings. Process Biochem. 2012, 47, 201-208.
68. Eby, D.M., Luckarift, H.R., Johnson, G.R., Hybrid antimicrobial enzyme and silver nanoparticle coatings for medical instruments. Appl. Mater. Interfaces 2009, 1, 1553-1560.
69. Bang, S.H., Jang, A., Yoon, J., Kim, P. et al., Evaluation of whole lysosomal enzymes directly immobilized on titanium (IV) oxide used in the development of antimicrobial agents. Enzyme Microb. Technol. 2011, 49, 260-265.
70. Wang, Q., Fan, X., Hu, Y., Yuan, J. et al., Antibacterial functionalization of wool fabric via immobilizing lysozymes. Bioprocess Biosyst. Eng. 2009, 32, 633-639.
71. Bower, C.K., Avena-Bustillos, R.J., Olsen, C.W., McHugh, T. H. et al., Characterization of fish-skin gelatin gels and films containing the antimicrobial enzyme lysozyme. J. Food Sci. 2006, 71, 141-145.
72. Park, S.I., Daeschel, M.A., Zhao, Y., Functional properties of antimicrobial lysozyme-chitosan composite films. J. Food Sci. 2004, 69, 215-221.
73. Craigen, B., Dashiff, A., Kadouri, D.E., The use of commercially available alpha-amylase compounds to inhibit and remove Staphylococcus aureus biofilms. Open Microbiol. J. 2011, 5, 21-31.
74. Oulahal-Lagsir, N., Martial-Gros, A., Bonneau, M., Blum, L.J., Escherichia coli-milk'' biofilm removal from stainless steel surfaces: synergism between ultrasonic waves and enzymes. Biofouling 2003, 19, 159-168.
75. Chaignon, P., Sadovskaya, I., Ragunah, C., Ramasubbu, N. et al., Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Appl. Microbiol. Biotechnol. 2007, 75, 125-132.
76. Darouiche, R.O., Mansouri, M.D., Gawande, P.V., Madhyastha, S., Antimicrobial and antibiofilm efficacy of triclosan and DispersinB{replacement character} combination. J. Antimicrob. Chemother. 2009, 64, 88-93.
77. Esperanza Torres, C., Lenon, G., Craperi, D., Wilting, R. et al., Enzymatic treatment for preventing biofilm formation in the paper industry. Appl. Microbiol. Biotechnol. 2011, 92, 95-103.
78. Wong, T.Y., Preston, L.A., Schiller, N.L., Alginate lyase: review of major sources and enzyme characteristics, structure-function analysis, biological roles, and applications. Annu. Rev. Microbiol. 2000, 54, 289-340.
79. Alkawash, M.A., Soothill, J.S., Schiller, N.L., Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. APMIS. 2006, 114, 131-138.
80. Gacesa, P., Alginate-modifying enzymes: A proposed unified mechanism of action for the lyases and epimerases. FEBS Lett. 1987, 212, 199-202.
81. Lamppa, J. W., Ackerman, M. E., Lai, J. I., Scanlon, T. C. et al., Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivity. PLoS ONE 2011, 6, e17042.
82. Kaplan, J.B., LoVetri, K., Cardona, S. T., Madhyastha, S. et al., Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci. Antibiot. 2012, 65, 73-77.
83. Nijland, R., Hall, M.J., Burgess, J.G., Dispersal of biofilms by secreted, matrix degrading, bacterial DNase. PLoS ONE 2010, 5, e15668.
84. Anitha, A., Rabeeth, M., Degradation of fungal cell walls of phytopathogenic fungi by lytic enzyme of Streptomyces griseus. Afr. J. Plant Sci. 2010, 4, 061-066.
85. Kucuk, C., Kivanc, M., In vitro antifungal activity of strains of Trichoderma harzianum. Turk. Biol. 2004, 28, 111-115.
86. Taechowisan, T., Peberdy, J., Lumyong, S., Chitinase production by endophytic Streptomyces aureofaciens CMUAc130 and its antagonism against phytopathogenic fungi. Ann. Microbiol., 2003, 53, 447-461.
87. Walker, S.L., Fourgialakis, M., Cerezo, B., Livens, S., Removal of microbial biofilms from dispense equipment: The effect of enzymatic pre-digestion and detergent Treatment. J. Inst. Brewing 2007, 113, 61-66.
88. Zanaroli, G., Negroni, A., Calisti, C., Ruzzi, M. et al., Selection of commercial hydrolytic enzymes with potential antifouling activity in marine environments. Enzyme Microb. Technol. 2011, 49, 574-579.
89. Orgaz, B., Kives, J., Pedregosa, A.M., Monistrol, I.F. et al., Bacterial biofilm removal using fungal enzymes. Enzyme Microb. Technol. 2006, 40, 51-56.
90. Curtin, J.F., Donovan, M., Cotter, T.G., Regulation and measurement of oxidative stress in apoptosis. J. Immunol. Methods 2002, 265, 49-72.
91. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D. et al., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44-84.
92. Klaunig, J.E., Kamendulis, L., Hocevar, B.A., Oxidative stress and oxidative damage in Carcinogenesis. Toxicol. Pathol. 2010, 38, 96-109.
93. Müller, D., Oxidation von Glukose mit Extrakten aus Aspergillus niger. Biochemisch Zeitschriften 1928, 199.
94. Leskovac, V., Trivic, S., Wohlfahrt, G., Kandrac, J. et al., Glucose oxidase from Aspergillus niger: the mechanism of action with molecular oxygen, quinones, and one-electron acceptors. Int. J. Biochem. Cell Biol. 2005, 37, 731-750.
95. Finnegan, M., Linley, E., Denyer, S.P., McDonnell, G. et al., Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms. J. Antimicrob. Chemother. 2010, 65, 2108-2115.
96. Alt, E., Leipold, F., Milatovic, D., Lehmann, G. et al., Hydrogen peroxide for prevention of bacterial growth on polymer biomaterials. Ann. Thorac. Surg. 1999, 68, 2123-2128.
97. Tiina, M., Sandholm, M., Antibacterial effect of the glucose oxidase-glucose system on food-poisoning organisms. Int. J. Food Microbiol. 1989, 8, 165-174.
98. Kantt, C., Torres, J., Growth-Inhibition by Glucose-Oxidase of selected organisms associated with the microbial spoilage of shrimp (Pandalus-Jordani) - In vitro model studies. J. Food Prot. 1993, 56, 147-152.
99. Dobbenie, D., Uyttendaele, M., Debevere, J., Antibacterial activity of the glucose Oxidase/glucose system in liquid whole egg. J. Food Prot. 1995, 58, 273-279.
100. Vartiainen, J., Rättö, M., Paulussen, S., Antimicrobial activity of glucose oxidase-immobilized plasma-activated polypropylene films. Packag Technol Sci 2005, 18, 243-251.
101. Ge, L., Zhao, Y., Mo, T., Li, J. et al., Immobilization of glucose oxidase in electrospun nanofibrous membranes for food preservation. Food Control 2012, 26, 188-193.
102. Yasin, M., Fewson, C.A., L(+)-Mandelate dehydrogenase from Rhodotorula graminis: purification, partial characterization and identification as a flavocytochrome b. Biochem. J. 1993, 293, 455-460.
103. Ludwig, R., Harreither, W., Tasca, F., Gorton, L., Cellobiose Dehydrogenase: a versatile catalyst for electrochemical applications. Chem. Phys. Chem. 2010, 11, 2674-2697.
104. Flitsch, A., Nugroho Prasetyo, E., Sygmund, C., Ludwig, R., Nyanhongo, G.S., Guebitz, G.M., Cellulose oxidation and bleaching processes based on recombinant Myriococcum thermophilum cellobiose dehydrogenase. Enzyme Microb. Technol. 2013, 60-67.
105. Nyanhongo, G.S., Sygmund, C., Ludwig, R., Nugroho Prasetyo, E., Synthesis of multifunctional bioresponsive polymers for the management of chronic wounds. J. Biomed. Mater. Res., Part B in press.
106. Nyanhongo, G.S., Sygmund, C., Ludwig, R., Nugroho Prasetyo, E. et al., An antioxidant regenerating system for continuous quenching of free radicals in chronic wounds. Eur. J. Pharm. Biopharm. - in press.
107. Hofmann, B., Tölzer, S., Pelletier, I., Altenbuchner, J. et al., Structural investigation of the cofactor-free chloroperoxidases. J. Mol. Biol. 1998, 279, 889-900.
108. Kussendrager, K.D., Van Hooijdonk, A.C.M., Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications. BJN. 2000, 84, 19-25.
109. Hanson, L.A., Biology of human milk, Nestle Nutrition Workshop Series, Raven Press, New York, 1988, pp. 45-61.
110. Reiter, B., Pickering, A., Oram, J.D., Pope, G. S., Peroxidase-thiocyanate inhibition of streptococci in raw milk. J. Gen. Microbiol. 1963, xii, 33.
111. Seifu, E., Buys, E. M., Donkin, E.F., Significance of the lactoperoxidase system in the dairy industry and its potential applications: a review. Trends Food Sci. Technol. 2005, 16, 137-154.
112. Tenovuo, J., Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis. 2002, 8, 23-2.
113. Boots, J.W., Floris, R., Lactoperoxidase: from catalytic mechanism to practical applications. Int. Dairy J. 2006, 16, 1272-1276.
114. Ratner, A. J., Prince, A., Lactoperoxidase. Am. J. Respir. Cell Mol. Biol. 2000, 22, 642-644.
115. Welk, A., Rudolph, P., Kreth, J., Schwahn, C. et al., Microbicidal efficacy of thiocyanate hydrogen peroxide after adding lactoperoxidase under saliva loading in the quantitative suspension test. Arch. Oral Biol. 2011, 56, 1576-1582.
116. Courtois, P., Candida biofilms on oral biomaterials, in: Dignantello, R. (Ed.), Biomaterials-Physics and Chemistry, InTech, 2011, pp. 475-490.
117. Kho, H., Kim, Y., Chang, J., Kim, M. et al., Candidacidal activities of the glucose oxidase-mediated lactoperoxidase system. Arch. Oral Biol. 2012, 57, 684-688.
118. Hannig, C., Spitzmüller, B., Lux, H. C., Altenburger, M. et al., Efficacy of enzymatic toothpastes for immobilisation of protective enzymes in the in situ pellicle. Arch. Oral Biol. 2010, 55, 463-469.
119. Hannig, C., Spies, B., Spitzmüller, B., Hannig, M., Efficacy of enzymatic mouth rinses for immobilisation of protective enzymes in the in situ pellicle. Arch. Oral Biol. 2010, 55, 1-6.
120. Agner, K., Verdoperoxidase, A ferment isolated from leucocytes. Acta chemica Scandinavica 1941, 2, 1-62.
121. Klebanoff, S.J., Myeloperoxidase: friend and foe. J. Leuk. Biol. 2005, 77, 598-625.
122. Tenovuo, J., Anttila, O., Lumikari, M., Sievers, G., Antibacterial effect of myeloperoxidase against Streptococcus mutans. Oral Microbiol. Immunol. 1988, 3, 68-71.
123. Borelli, V., Banfi, E., Perrotta, G. P., Zabucchi, G., Myeloperoxidase exerts microbicidal activity against Mycrobacterium tuberculosis. Infect. Immun. 1999, 67, 4149-4152.
124. Chochola, J., Yamaguchi, Y., Moguilevsky, N., Bollen, A. et al., Virucidal effect of myeloperoxidase on human immunodeficiency virus type 1-infected T cells. Antimicrob. Agents Chemother. 1994, 38, 969-972.
125. Amitai, G., Andersen, J., Wargo, S., Asche, G. et al., Polyurethane-based leukocyte-inspired biocidal materials. Biomaterials 2009, 30, 6522-6529.
126. Persoon, I.F., Hoogenkamp, M. A., Bury, A., Wesselink, P.R. et al., Effect of vanadium chloroperoxidase on Enterococcus faecalis biofilms. J. Endod. 2012, 38, 72-74.
127. Hoogenkamp, M.A., Crielaard, W., Ten Cate, J.M., Wever, R., Hartog, A.F. et al., Antimicrobial activity of vanadium chloroperoxidase on planktonic Streptococcus mutans cells and Streptococcus mutans biofilms. Caries Res. 2009, 43, 334-338.
128. Hansen, E.H., Schäfer, T., Molin, S., Gram, L., Effect of environmental and physiological factors on the antibacterial activity of Curvularia haloperoxidase system against Escherichia coli. J. Appl. Microbiol. 2005, 98, 581-588.
129. Hansen, E. H., Albertsen, L., Schäfer, T., Johansen, C. et al., Curvularia haloperoxidase: antimicrobial activity and potential application as a surface disinfectant. Appl. Environ Microbiol. 2003, 69, 4611-4617.
130. Dong, Y., Zhang, L.H., Quorum sensing and quorum-quenching enzymes. J. Microbiol. 2005, 43, 101-109.
131. Pearson, J. P., Van Delden, C., Iglewski, B. H., Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 1999, 181, 1203-1210.
132. Dong, Y.H., Xu, J.L., Li, X.Z., Zhang, L.H., AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of Erwinia carotovora. Proc. Natl. Acad. Sci. USA. 2000, 28, 3526-3531.
133. Dong, Y.H., Wang, LH., Xu, J.L., Zhang, H.B. et al., Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase. Nature 2001, 411, 813-817.
134. Xu, F., Byun, T., Deussen, H.J., Duke, K.R., Degradation of N-acylhomoserine lactones, the bacterial quorum-sensing molecules, by acylase. J. Biotechnol. 2003, 101, 89-96.
135. Chun, C.K., Ozer, E. A., Welsh, M.J., Zabner, J. et al., Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proc. Natl. Acad. Sci. USA 2004, 101, 3587-3590.
136. Molina, L., Constantinescu, F., Michel, L., Reimmann, C. et al., Degradation of pathogen quorum-sensing molecules by soil bacteria: a preventive and curative biological control mechanism. FEMS Microbiol. Ecol. 2003, 45, 71-81.
137. Lu, T.K., Collins, J. J., Dispersing biofilms with engineered enzymatic bacteriophage. Proc. Natl. Acad. Sci. USA 2007, 104, 11197-11202.
138. Climo, M.W., Ehlert, K., Archer, G.L., Mechanism and suppression of lysostaphin resistance inoxacillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2001, 45, 1431-1437.
139. Strandén, A.M., Ehlert, K., Labischinski, H., Berger-Bächi, B., Cell wall monoglycine crossbridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 1997, 179, 9-16.
140. Climo, M.W., Patron, R.L., Goldstein, B.P., Archer, G.L., Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob Agents Chemother. 1998, 42, 1355-1360.
141. Harrisa, A.G., Hinds, F.E., Beckhouse, AG., Kolesnikow, T., Stuart, L.H., Resistance to hydrogen peroxide in Helicobacter pylori: role of catalase (KatA) and Fur, and functional analysis of a novel gene product designated 'KatA-associated protein', KapA (HP0874) Microbiol. 2002, 148, 3813-25.
142. De Spiegeleer, P., Vanoirbeek, K., Lietaert, A., Sermon, J., Aertsen, A., Michiels, C.W., Investigation into the resistance of lactoperoxidase tolerant Escherichia coli mutants to different forms of oxidative stress. FEMS Microbiol Lett. 2005, 252, 315-9.
143. Loeffler, J.M., Nelson, D., Fischetti, V.A., Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 2001, 7, 2170-2172.
144. Fischetti, V.A., Novel method to control pathogenic bacteria on human mucous membranes. Ann. NY Acad. Sci. 2003, 987, 207-214.
145. Schuch, R., Nelson, D., Fischetti, V.A., A bacteriolytic enzyme that detects and kills Bacillus anthracis. Nature 2002, 418, 884-889.